Barclays’s Intellipharmaceutics International IPCI Stock Holding History
Bought
Maintained
Sold
Other funds holding IPCI
SM
Barclays's IPCI Position: Q4 2018 in Review
Barclays sold out of Intellipharmaceutics International (IPCI) in Q4 2018, closing a stake of 1,775 shares — an estimated $5K sold.
Barclays first reported a position in IPCI in Q1 2018 and held it in 3 quarters. The position peaked at $13K in Q2 2018. 12 funds tracked by Wall St. Rank hold IPCI as of Q4 2018.
- Barclays reported no remaining Intellipharmaceutics International position as of Q4 2018 after selling out during the quarter.
- Barclays sold 1,775 Intellipharmaceutics International shares in Q4 2018, an estimated $5K.
- Barclays first reported a position in Intellipharmaceutics International in Q1 2018 and held it in 3 quarters.
- Barclays's Intellipharmaceutics International position peaked at $13K in Q2 2018.
- 12 funds tracked by Wall St. Rank held Intellipharmaceutics International as of Q4 2018.
Based on Barclays's 13F filing for Q4 2018, filed 14 Feb 2019.